Supreme Court's Glyphosate Case: Awaiting Solicitor General's Opinion
Bayer awaits the U.S. Supreme Court's decision on its weedkiller, glyphosate. The court has asked for the solicitor general's opinion, delaying proceedings. Bayer seeks clarity amidst claims of cancer risks, while asserting that the EPA deems glyphosate safe. Bayer's shares fell 4.2% following the update.
The U.S. Supreme Court has requested input from the solicitor general in the ongoing case involving Bayer's glyphosate weedkiller. This development introduces further delays in determining whether the court will hear the case, as Bayer seeks resolution for potential liabilities in the billions related to cancer claims.
Germany-based Bayer remains optimistic, with CEO Bill Anderson calling the court's request a promising step. The company eagerly anticipates the government's stance, as per the U.S. Environmental Protection Agency's guidance that glyphosate is not carcinogenic, nor a risk to public health when used correctly.
Despite Bayer's confidence, the company's shares slid 4.2% at 1354 GMT, amid the ongoing legal complexities and public scrutiny surrounding glyphosate's safety and marketing practices.
(With inputs from agencies.)
Google News